We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.
- Authors
Stadler, Walter M; Rosner, Gary; Small, Eric; Hollis, Donna; Rini, Brian; Zaentz, S Donald; Mahoney, John; Ratain, Mark J
- Abstract
To assess the disease-stabilizing activity of carboxyaminoimidazole (CAI) in patients with metastatic renal cell cancer (RCC) using a randomized discontinuation trial (RDT) design.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 16, p3726
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.44.150